{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:51:40Z","timestamp":1790520700071,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejrad.2017.11.007","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:48:41Z","timestamp":1510706921000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"98","author":[{"given":"Guangyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2017.11.007_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0010","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0020","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","article-title":"Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0025","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus Concurrent Chemoradiotherapy followed by adjuvant chemotherapy in patients with american joint committee on Cancer\/International union against Cancer Stage III and IV nasopharyngeal cancer of the Endemic variet","volume":"23","author":"Wee","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0030","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J. Clin Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0035","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.28049","volume":"119","author":"Chen","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2010.10.026","article-title":"Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials","volume":"47","author":"Lee","year":"2011","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","article-title":"Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0050","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial","volume":"103","author":"Chen","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0060","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0065","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00259-005-1837-5","article-title":"Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"32","author":"Yen","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0070","doi-asserted-by":"crossref","first-page":"24835","DOI":"10.1038\/srep24835","article-title":"The tumour response to induction chemotherapy has prognostic value for long-term survival outcomes after intensity-modulated radiation therapy in nasopharyngeal carcinoma","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0075","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2015.08.003","article-title":"The prognostic value of plasma epstein-barr viral DNA and tumor response to neoadjuvant chemotherapy in advanced-stage nasopharyngeal carcinoma","volume":"93","author":"Liu","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/RCT.0b013e31829a2599","article-title":"Early assessment of induction chemotherapy response of nasopharyngeal carcinoma by pretreatment diffusion-weighted magnetic resonance imaging","volume":"37","author":"Zheng","year":"2013","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0085","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.mri.2014.02.009","article-title":"Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma","volume":"32","author":"Chen","year":"2014","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0090","first-page":"1528","article-title":"Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: value of dynamic contrast-enhanced 3.0T MRI","volume":"0","author":"Zheng","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mri.2016.08.011","article-title":"Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging","volume":"35","author":"Zheng","year":"2017","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0100","first-page":"1179","article-title":"Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma","volume":"24","author":"Xiao-Ping","year":"2015","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0105","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1097\/MD.0000000000000973","article-title":"Intravoxel incoherent motion-magnetic resonance imaging as an early predictor of treatment response to neoadjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma","volume":"94","author":"Xiao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0110","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-15-2997","article-title":"Rectal cancer assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI","volume":"22","author":"Nie","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1148\/radiol.2016152110","article-title":"MR imaging radiomics signatures for predicting the risk of Breast cancer recurrence as given by research versions of MammaPrint, oncotype DX, and PAM50 gene assays","volume":"281","author":"Li","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmri.25156","article-title":"Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma","volume":"44","author":"Liu","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0125","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-16-2910","article-title":"Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0130","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2009"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2017.11.007_bib0150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/0003-4819-138-8-200304150-00012","article-title":"Multivariable analysis: a primer for readers of medical research","volume":"138","author":"Katz","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejrad.2012.10.023","article-title":"Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis?","volume":"82","author":"Ng","year":"2013","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2017.11.007_bib0160","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00261-015-0438-4","article-title":"CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes","volume":"40","author":"Lubner","year":"2015","journal-title":"Abdom. Imaging"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X17304977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X17304977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T02:27:33Z","timestamp":1535250453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X17304977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"alternative-id":["S0720048X17304977"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2017.11.007","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}